Dartmouth SYNERGY | Clinical and Translational Science Institute

Fostering discovery, improving infrastructure, nurturing collaboration, enhancing training, and facilitating the translation of discovery into practice.

SYNERGY Highlights

Highlights archive


NCATS announces funding for Pre-clinical Research Based on Existing Repurposing Tools

The NIH - National Center for Advancing Translational Sciences (NCATS) announces the availability of funding for Pre-clinical Research Based on Existing Repurposing Tools (R21) - RFA-TR-16-001. This Funding Opportunity Announcement (FOA) will support rigorous, pre-clinical studies that establish the rationale for a clinical trial, where the hypothesis originates from use of a published or publicly available method for identifying new indications for existing drugs or biologics (therapeutics). Due Date: LOI due December 13, 2015 Amount of Funding: $400,000 over two years


Dartmouth SYNERGY Offers a Big Boost to Clinical Research

“We all need somebody to lean on,” wrote singer-songwriter Bill Withers in 1972. His wise advice is especially appropriate for scientists on the long, tricky road of translational and clinical research. The team of people behind Dartmouth SYNERGY, the Dartmouth Clinical and Translational Science Institute, are providing that kind of support for junior biomedical scientists committed to improving patients’ health. SYNERGY helps junior researchers take their biomedical research findings and leverage them into new treatments for patients through a huge range of research tools and clinical research support.

News archive